140 related articles for article (PubMed ID: 37403167)
21. Synchronous parathyroid carcinoma, parathyroid adenoma, and papillary thyroid carcinoma in a patient with severe and long-standing hyperparathyroidism.
Goldfarb M; O'Neal P; Shih JL; Hartzband P; Connolly J; Hasselgren PO
Endocr Pract; 2009; 15(5):463-8. PubMed ID: 19491068
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and morphological characteristics of parathyroid carcinoma].
Voronkova IA; Mokrysheva NG; Kazantseva IA; Gurevich LE
Arkh Patol; 2018; 80(4):65-72. PubMed ID: 30059074
[TBL] [Abstract][Full Text] [Related]
23. Intraoperative diagnostic strategy to distinguish parathyroid adenomas from metastatic thyroid cancer.
Guerrero MA; Vriens MR; Suh I; Khanafshar E; Clark OH
Endocr Pract; 2009; 15(5):454-7. PubMed ID: 19491067
[TBL] [Abstract][Full Text] [Related]
24. Effect of tumor volume on the enhancement pattern of parathyroid adenoma on parathyroid four-dimensional CT.
Lee EK; Yun TJ; Kim JH; Lee KE; Kim SJ; Won JK; Kang KM; Choi SH; Sohn CH
Neuroradiology; 2016 May; 58(5):495-501. PubMed ID: 26847704
[TBL] [Abstract][Full Text] [Related]
25. Combined parathyroid adenoma and an occult papillary carcinoma.
Meshikhes AW; Butt SA; Al-Saihati BA
Saudi Med J; 2004 Nov; 25(11):1707-10. PubMed ID: 15573208
[TBL] [Abstract][Full Text] [Related]
26. Deoxyribonucleic acid cytometry helps identify parathyroid carcinomas.
Levin KE; Chew KL; Ljung BM; Mayall BH; Siperstein AE; Clark OH
J Clin Endocrinol Metab; 1988 Oct; 67(4):779-84. PubMed ID: 3417849
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological features of recurrent papillary thyroid cancer.
Zhu J; Wang X; Zhang X; Li P; Hou H
Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921
[TBL] [Abstract][Full Text] [Related]
28. Papillary thyroid carcinoma, parathyroid adenoma, and unexplained hypercalcitoninemia: an unusual presentation of multiple endocrine neoplasia type 2A?
Rone JK; Lane AG; Grinkemeyer MD
Thyroid; 1998 Sep; 8(9):781-5. PubMed ID: 9777749
[TBL] [Abstract][Full Text] [Related]
29. Intrathyroidal oncocytic parathyroid adenoma: a diagnostic pitfall on fine-needle aspiration.
Paker I; Yilmazer D; Yandakci K; Arikok AT; Alper M
Diagn Cytopathol; 2010 Nov; 38(11):833-6. PubMed ID: 20301208
[TBL] [Abstract][Full Text] [Related]
30. Immunoperoxidase staining in the differential diagnosis of parathyroid from thyroid origin in fine needle aspirates of suspected parathyroid lesions.
Chang TC; Tung CC; Hsiao YL; Chen MH
Acta Cytol; 1998; 42(3):619-24. PubMed ID: 9622678
[TBL] [Abstract][Full Text] [Related]
31. Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms.
Silva-Figueroa AM; Bassett R; Christakis I; Moreno P; Clarke CN; Busaidy NL; Grubbs EG; Lee JE; Perrier ND; Williams MD
Endocr Pathol; 2019 Dec; 30(4):285-296. PubMed ID: 31734935
[TBL] [Abstract][Full Text] [Related]
32. Parathyroid hormone assay in fine-needle aspirate is useful in differentiating inadvertently sampled parathyroid tissue from thyroid lesions.
Owens CL; Rekhtman N; Sokoll L; Ali SZ
Diagn Cytopathol; 2008 Apr; 36(4):227-31. PubMed ID: 18335560
[TBL] [Abstract][Full Text] [Related]
33. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
[TBL] [Abstract][Full Text] [Related]
34. High Expression of Yes-activated Protein-1 in Papillary Thyroid Carcinoma Correlates With Poor Prognosis.
Liu Z; Zeng W; Maimaiti Y; Ming J; Guo Y; Liu Y; Liu C; Huang T
Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):59-64. PubMed ID: 28682834
[TBL] [Abstract][Full Text] [Related]
35. Aspiration cytology of parathyroid adenoma: radioimmunoassay of parathormone in aspirate as a helpful diagnostic tool.
Ryşka A; Kerekes Z; Cáp J
Acta Cytol; 1998; 42(3):826-7. PubMed ID: 9622722
[No Abstract] [Full Text] [Related]
36. Lipoadenoma: is it arising from thyroid or parathyroid? A diagnostic dilemma.
Sheikh SS; Massloom HS
ORL J Otorhinolaryngol Relat Spec; 2002; 64(6):448-50. PubMed ID: 12499772
[TBL] [Abstract][Full Text] [Related]
37. An unusual case of synchronous thyroid and parathyroid adenomas.
Huston BM; Landas SK
Head Neck; 1994; 16(4):372-4. PubMed ID: 8056583
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
Meng XY; Zhang Q; Li Q; Lin S; Li J
J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
[TBL] [Abstract][Full Text] [Related]
39. Functional parathyroid carcinoma. Cytology, histology, and ultrastructure of a case.
de la Garza S; Flores de la Garza E; Hernández Batres F
Diagn Cytopathol; 1985; 1(3):232-5. PubMed ID: 3836090
[TBL] [Abstract][Full Text] [Related]
40. Level V Metastasis, a Novel Predicative Factor for Recurrence in N1b Papillary Thyroid Carcinoma.
Wu Y; Li J; Wu X; Dai L
Curr Pharm Des; 2018; 24(5):559-563. PubMed ID: 28990528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
